CAPTRUST Financial Advisors’s BioCardia, Inc. Warrant BCDAW Stock Holding History

CAPTRUST Financial Advisors’s Portfolio BCDAW Stock Details BCDAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-500,000	Closed	-$175K	–	4275
2022 Q2	$175K	Hold	500,000	–	–	﹤0.01%	1784
2022 Q1	$151K	Hold	500,000	–	–	﹤0.01%	1934
2021 Q4	$555K	Hold	500,000	–	–	﹤0.01%	1065
2021 Q3	$812K	Hold	500,000	–	–	0.01%	836
2021 Q2	$734K	Hold	500,000	–	–	0.01%	841
2021 Q1	$690K	Hold	500,000	–	–	0.01%	828
2020 Q4	$770K	Hold	500,000	–	–	0.01%	689
2020 Q3	$310K	Hold	500,000	–	–	0.01%	864
2020 Q2	$276K	Buy	+500,000	New	+$478K	﹤0.01%	898

Other funds holding BCDAW

EAM

Empery Asset Management New York $83M AUM

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

GenTrust Miami, Florida $2.34B AUM 18.43% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CAPTRUST Financial Advisors's BCDAW Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of BioCardia, Inc. Warrant (BCDAW) in Q3 2022, closing a stake of 500,000 shares — an estimated $175K sold.

CAPTRUST Financial Advisors first reported a position in BCDAW in Q2 2020 and held it in 9 quarters. The position peaked at $812K in Q3 2021. 5 funds tracked by Wall St. Rank hold BCDAW as of Q3 2022.

CAPTRUST Financial Advisors reported no remaining BioCardia, Inc. Warrant position as of Q3 2022 after selling out during the quarter.
CAPTRUST Financial Advisors sold 500,000 BioCardia, Inc. Warrant shares in Q3 2022, an estimated $175K.
CAPTRUST Financial Advisors first reported a position in BioCardia, Inc. Warrant in Q2 2020 and held it in 9 quarters.
CAPTRUST Financial Advisors's BioCardia, Inc. Warrant position peaked at $812K in Q3 2021.
5 funds tracked by Wall St. Rank held BioCardia, Inc. Warrant as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.